SlideSpeak vs Visme affiliate programs
SlideSpeak and Visme are AI presentations tools that both run affiliate programs. SlideSpeak lists 30% for 12 months through PromoteKit; Visme lists 25%. One of the two does not state a cookie window, so the attribution windows cannot be compared. aifilliate records each program from a cited vendor source and does not rank the two.
| Recorded term | SlideSpeak Verified | Visme Verified |
|---|---|---|
| Commission | 30% for 12 months | 25% |
| Structure | Recurring | Recurring |
| Cookie window | Not stated | 60 days |
| Network | PromoteKit | Not stated |
| Payout threshold | $100 | $150 |
| Terms checked | 2026-08-20 | 2026-08-22 |
| Source | Open source ↗ | Open source ↗ |
What matches, what differs
Differences
- SlideSpeak pays out at a lower balance: $100 against $150.
In common
- Both are AI presentations tools.
- Both pay recurring commission.
Which record fits which promoter
- SlideSpeak: reaches a first payout sooner — its minimum starts at $100.
- Visme: holds commissions until $150, which suits promoters expecting larger, less frequent payouts.
What is not published
Anything below has to be confirmed with the vendor before either offer can be modelled. aifilliate records it as unknown rather than estimating it.
- SlideSpeak does not publish a cookie window.
- Visme does not publish the platform running the program.
How to read these two records
Both rates are stated as percentages of customer payments, so the figures share a basis. They may still cover different plans, billing terms, and eligibility rules.
Both pay recurring commission. One of the two does not state a cookie window, so the attribution windows cannot be compared.
aifilliate publishes no ranking between SlideSpeak and Visme. Which program earns more depends on plan price, conversion rate, retention, and refund reversals in your own audience — none of which appear in published affiliate terms. Confirm eligibility, paid-search and trademark rules, and payout timing with each vendor before promoting either.